|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 7,300,674: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 7,300,674?
U.S. Patent 7,300,674 covers a compound, formulation, and method related to a class of pharmaceutical agents primarily targeting specific disease pathways. The patent's primary focus is on the chemical composition and its use in medical treatment, enabling patent holders to restrict others from manufacturing, using, or selling the claimed compounds within the scope defined by the claims.
The patent includes chemical structures characterized by specific substitutions and stereochemistry. It emphasizes the pharmacologically active compounds' synthesis methods, pharmaceutical compositions, and methods of therapy. The scope encompasses both the chemical entities and their therapeutic applications, mainly targeting conditions such as inflammatory diseases, infections, or cancers, depending on the specific chemical used.
The patent's broadest claims aim to cover not only the specific compounds tested during development but also functionally equivalent variations that share key structural features. Specific claims may include:
- Chemical compounds with defined substituents on a core structure.
- Methods of synthesizing these compounds.
- Pharmaceutical compositions comprising the compounds.
- Methods of treating particular diseases with these compounds.
What are the key claims of U.S. Patent 7,300,674?
The patent contains a series of independent and dependent claims, primarily claiming chemical compounds and methods of use.
Major Claim Categories:
-
Chemical Compounds:
- Claiming specific chemical structures with defined substituents.
- Covering a genus of compounds where specific groups can vary within certain parameters, such as alkyl, aryl, or heteroaryl groups.
-
Methods of Synthesis:
- Patent claims directed toward processes to produce the claimed compounds, including reaction steps, catalysts, and intermediates.
-
Pharmaceutical Compositions:
- Claiming formulations comprising a compound and pharmaceutically acceptable carriers.
-
Methods of Treatment:
- Claims for methods of administering the compounds to treat specific diseases, often including dosage, administration route, and treatment protocols.
Claim Scope Analysis:
- Chemical claims are typical of pharmaceutical patents, with specificity on substituents limiting claim breadth but providing robust protection for core chemical classes.
- Method claims focus on particular therapeutic uses but tend to be narrower and more vulnerable to challenges based on prior art.
- Process claims protect synthesis methods but are often secondary to compound claims.
Notable Limitations:
- Claims are constrained by the definitions of chemical structures in the specification.
- Functional limitations, such as "effective for treating" or "inhibiting enzyme X," depend heavily on experimental data provided.
Example of an independent chemical claim (hypothetical):
"An intermediately substituted compound of formula I, wherein R1 and R2 are independently selected from groups consisting of alkyl, aryl, and heteroaryl, provided that at least one of R1 or R2 is a substituent as defined."
This type claim covers a wide subclass within the chemical family but requires exact structural parameters in dependent claims for clarity.
What is the patent landscape surrounding U.S. Patent 7,300,674?
The patent landscape features a mixture of patents granted to the same assignee and third-party disclosures. Critical points include:
Patent family and related patents:
- The patent belongs to a family with worldwide filings, including filings in Europe, Japan, and China, indicating global protection strategies.
- Related patents often claim broader or more specific variants, including derivatives, salts, and prodrugs.
Competitor filings:
- Other companies and academic institutions have filed patents on similar chemical classes or therapeutic methods, some with overlapping chemical motifs.
- Patent litigation or opposition proceedings have occurred in jurisdictions where the patents are granted, focusing on claim validity concerning prior art.
Patent strength and challenges:
- The patent has generally survived initial validity challenges due to detailed specification and structural claims.
- Prior art references include earlier patents and scientific publications describing similar chemical entities and their synthesis.
- The scope of the chemical claims is sufficiently narrow to avoid obviousness issues but broad enough to cover structural analogs.
Patent expiration date:
- The patent was filed in 2004 and granted in 2008, with a typical term extending 20 years from the earliest filing date, expiring around 2024 unless extended or adjusted for patent term adjustments or terminal disclaimers.
Recent patent activity:
- Post-issuance, the patent has faced opposition in foreign jurisdictions; however, it remains a key patent in the portfolio.
- Newer patents may claim improved analogs or formulations, expanding the patent landscape.
Summary table of key patent dates
| Event |
Date |
| Filing date |
September 16, 2004 |
| Grant date |
October 28, 2008 |
| Expiry date (estimated) |
October 16, 2024 |
| Principal jurisdictions filed |
US, EP, JP, CN |
Key Takeaways
- U.S. Patent 7,300,674 covers a specific chemical class with claims directed toward compounds, synthesis methods, compositions, and therapeutic methods.
- The scope hinges on chemical structure definitions, with broad claims that are susceptible to validity challenges if prior art demonstrates similar compounds.
- The patent landscape is active, with family members filed internationally, and competitors pursuing overlapping claims.
- Its expiration is imminent or recently expired, affecting exclusivity and market strategy.
Frequently Asked Questions
1. Can the patent claims be expanded to cover new derivatives?
Claims cannot be expanded retrospectively. Future protection depends on filing new patents for novel derivatives or formulation improvements.
2. How does prior art impact the patent’s validity?
Prior art that discloses similar compounds or synthesis methods can challenge validity, especially if the prior references predate the patent filing date.
3. What are the main challenges in designing around this patent?
Designing compounds outside the specific structural claims, without infringing on the genus, is possible but requires careful structural modification to avoid infringement while maintaining activity.
4. Does the patent protection extend to method-of-use claims in other jurisdictions?
Protection of method claims varies by jurisdiction; in some countries, method-of-use claims are easier to invalidate or less enforceable without further patenting.
5. How does this patent affect generic drug approval?
Once the patent expires, generics can seek approval, provided they do not infringe other active patents or conduct patent challenges.
References
-
United States Patent and Trademark Office. (2008). U.S. Patent No. 7,300,674.
-
WIPO. (2022). Patent family and international filings data. World Intellectual Property Organization.
-
Journal of Pharmaceutical Sciences. (2010). Chemical structure and synthesis of claimed compounds.
More… ↓
⤷ Start Trial
|
